These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 27130973

  • 1. [Economic Short-Term Cost Model for Stereotactic Radiotherapy of Neovascular AMD].
    Neubauer AS, Reznicek L, Minartz C, Ziemssen F.
    Klin Monbl Augenheilkd; 2016 Aug; 233(8):951-7. PubMed ID: 27130973
    [Abstract] [Full Text] [Related]

  • 2. [Interest of optical coherence tomography performed immediately before intravitreal injection of anti-VEGF in exudative AMD].
    Moyal L, Cohen SY, Pedinielli A, Semoun O, Lalloum F, Jung C, Souied E.
    J Fr Ophtalmol; 2015 Sep; 38(7):573-9. PubMed ID: 25997681
    [Abstract] [Full Text] [Related]

  • 3. Microvascular abnormalities secondary to radiation therapy in neovascular age-related macular degeneration: findings from the INTREPID clinical trial.
    Freiberg FJ, Michels S, Muldrew A, Slakter J, O'Shaughnessy D, Czeszynski A, Danielson L, Jackson TL, Chakravarthy U.
    Br J Ophthalmol; 2019 Apr; 103(4):469-474. PubMed ID: 29930098
    [Abstract] [Full Text] [Related]

  • 4. Bevacizumab for neovascular age-related macular degeneration using a treat-and-extend regimen: clinical and economic impact.
    Shienbaum G, Gupta OP, Fecarotta C, Patel AH, Kaiser RS, Regillo CD.
    Am J Ophthalmol; 2012 Mar; 153(3):468-473.e1. PubMed ID: 21996309
    [Abstract] [Full Text] [Related]

  • 5. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
    Veloso CE, Kanadani TM, Pereira FB, Nehemy MB.
    Ophthalmology; 2015 Aug; 122(8):1569-72. PubMed ID: 26038338
    [Abstract] [Full Text] [Related]

  • 6. Defining response to anti-VEGF therapies in neovascular AMD.
    Amoaku WM, Chakravarthy U, Gale R, Gavin M, Ghanchi F, Gibson J, Harding S, Johnston RL, Kelly SP, Lotery A, Mahmood S, Menon G, Sivaprasad S, Talks J, Tufail A, Yang Y.
    Eye (Lond); 2015 Jun; 29(6):721-31. PubMed ID: 25882328
    [Abstract] [Full Text] [Related]

  • 7. [The treatment of the exsudative age-related macular degeneration with choroidal neovascular membrane, its possibilities and economical indexes].
    Karel I.
    Cesk Slov Oftalmol; 2007 Sep; 63(5):311-9. PubMed ID: 17915581
    [Abstract] [Full Text] [Related]

  • 8. Macular atrophy in patients with long-term anti-VEGF treatment for neovascular age-related macular degeneration.
    Munk MR, Ceklic L, Ebneter A, Huf W, Wolf S, Zinkernagel MS.
    Acta Ophthalmol; 2016 Dec; 94(8):e757-e764. PubMed ID: 27417506
    [Abstract] [Full Text] [Related]

  • 9. Ranibizumab (Lucentis) versus Bevacizumab (Avastin) for the Treatment of Age-Related Macular Degeneration: An Economic Disparity of Eye Health.
    Moreno TA, Kim SJ.
    Semin Ophthalmol; 2016 Dec; 31(4):378-84. PubMed ID: 27116030
    [Abstract] [Full Text] [Related]

  • 10. [Anti VEGF Therapy Under Real-Life Conditions: Adherance Determines Long Term Outcome in Neovascular AMD].
    Sachs HG, Wilke RG.
    Klin Monbl Augenheilkd; 2016 Aug; 233(8):958-64. PubMed ID: 26789120
    [Abstract] [Full Text] [Related]

  • 11. Potential selection bias in candidates for stereotactic radiotherapy for neovascular AMD.
    Ehlken C, Böhringer D, Agostini HT, Grundel B, Stech M.
    Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):105-111. PubMed ID: 29168044
    [Abstract] [Full Text] [Related]

  • 12. [Adjuvant radiotherapy during anti-VEGF in neovascular age-related macular degeneration].
    Rating P, Freimuth MA, Stuschke M, Bornfeld N.
    Ophthalmologe; 2017 Apr; 114(4):370-374. PubMed ID: 28220249
    [Abstract] [Full Text] [Related]

  • 13. One-year results from clinical practice of epimacular strontium-90 brachytherapy for the treatment of subfoveal choroidal neovascularization secondary to AMD.
    Zur D, Loewenstein A, Barak A.
    Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):338-43. PubMed ID: 25856820
    [Abstract] [Full Text] [Related]

  • 14. Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID study.
    Jackson TL, Chakravarthy U, Kaiser PK, Slakter JS, Jan E, Bandello F, O'Shaughnessy D, Gertner ME, Danielson L, Moshfeghi DM, INTREPID Study Group.
    Ophthalmology; 2013 Sep; 120(9):1893-900. PubMed ID: 23490327
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of treating wet age-related macular degeneration at the Kuopio University Hospital in Finland based on a two-eye Markov transition model.
    Vottonen P, Kankaanpää E.
    Acta Ophthalmol; 2016 Nov; 94(7):652-656. PubMed ID: 27481048
    [Abstract] [Full Text] [Related]

  • 16. Variants in the VEGFA gene and treatment outcome after anti-VEGF treatment for neovascular age-related macular degeneration.
    Abedi F, Wickremasinghe S, Richardson AJ, Makalic E, Schmidt DF, Sandhu SS, Baird PN, Guymer RH.
    Ophthalmology; 2013 Jan; 120(1):115-21. PubMed ID: 23149126
    [Abstract] [Full Text] [Related]

  • 17. Disease Burden in the Treatment of Age-Related Macular Degeneration: Findings From a Time-and-Motion Study.
    Prenner JL, Halperin LS, Rycroft C, Hogue S, Williams Liu Z, Seibert R.
    Am J Ophthalmol; 2015 Oct; 160(4):725-31.e1. PubMed ID: 26142721
    [Abstract] [Full Text] [Related]

  • 18. Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration: Data from an Observational Study.
    Gillies MC, Campain A, Barthelmes D, Simpson JM, Arnold JJ, Guymer RH, McAllister IL, Essex RW, Morlet N, Hunyor AP, Fight Retinal Blindness Study Group.
    Ophthalmology; 2015 Sep; 122(9):1837-45. PubMed ID: 26096346
    [Abstract] [Full Text] [Related]

  • 19. Clinical utilization of anti-VEGF agents and disease monitoring in neovascular age-related macular degeneration.
    Holekamp NM, Liu Y, Yeh WS, Chia Y, Kiss S, Almony A, Kowalski JW.
    Am J Ophthalmol; 2014 Apr; 157(4):825-833.e1. PubMed ID: 24388973
    [Abstract] [Full Text] [Related]

  • 20. Anti vascular endothelial growth factor sequential therapy for neovascular age-related macular degeneration: is this the new deal?
    Neri P, Mariotti C, Arapi I, Bambini E, Giovannini A.
    Curr Med Res Opin; 2012 Mar; 28(3):395-400. PubMed ID: 22283373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.